Illumina Inc (ILMN)
300.00
-3.20 -1.06%
NASDAQ
Feb 20, 16:59
Delayed 2m
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 3.543B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 6.75 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 1.002B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 69.54% |
| Profit Margin (Quarterly) | 25.10% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0% |
| Price and Valuation | |
| Market Cap | 44.10B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 12.60 |
| PE Ratio | 44.44 |
| Price to Book Value | 9.560 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.2473 |
| Free Cash Flow (Quarterly) | 386.00M |
| Return on Equity | Upgrade |
View All ILMN News
News
-
WireHeadlineTime (ET)
-
Yahoo02/20 16:09
-
Yahoo02/19 14:03
-
Yahoo02/17 17:44
-
Business Wire02/12 16:22
-
Yahoo02/07 07:33
-
Business Wire02/06 16:05
-
Yahoo02/06 15:43
-
Yahoo02/02 08:35
-
Yahoo01/31 10:08
-
Yahoo01/30 17:45
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 04/24/2020 14:00 PDT | Misc | Illumina Inc First Quarter Earnings Conference Call in 2020 |
| 04/24/2020 | Earnings | Illumina Inc First Quarter Earnings in 2020 Release |
| 02/11/2020 | Misc | Illumina Inc Annual Report for 2019 |
| 01/29/2020 17:00 EST | Misc | Illumina Inc Fourth Quarter Earnings Conference Call for 2019 |
| 01/29/2020 | Earnings | Illumina Inc Fourth Quarter Earnings in 2019 Release |
| 10/24/2019 14:00 PDT | Misc | Illumina Inc Third Quarter Earnings Conference Call for 2019 |
| 10/24/2019 | Earnings | Illumina Inc Third Quarter Earnings in 2019 Release |
| 07/29/2019 17:00 EDT | Misc | Illumina Inc Second Quarter Earnings Conference Call in 2019 |
| 07/29/2019 | Earnings | Illumina Inc Second Quarter Earnings in 2019 Release |
| 05/29/2019 10:00 PDT | Misc | Illumina Inc Annual General Meeting in 2018 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.illumina.com
- Investor Relations URL: http://www.illumina.com/company/investor-information.html
- HQ State/Province: California
- Sector: Healthcare
- Industry: Diagnostics & Research
- Equity Style: Large Cap/Growth
- Next Earnings Release: Apr. 24, 2020
- Last Earnings Release: Jan. 29, 2020
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates revenue from sequencing tools and dedicated consumables (73% of 2019 sales). Illumina’s high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. Services account for 17% of sales and include basic maintenance services, clinical lab applications (such as noninvasive prenatal, oncology, and rare-disease screening), and whole genome sequencing.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 300.00 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| ARKG | ARK Genomic Revolution ETF | 10.14% |
| ARKK | ARK Innovation ETF | 7.03% |
| IBB | iShares Nasdaq Biotechnology ETF | 5.23% |
| HQL | Tekla Life Sciences Investors | 5.07% |
| MGHRX | Morgan Stanley Inst Growth IR | 4.95% |
| BBH | VanEck Vectors Biotech ETF | 4.53% |
| EGFFX | Edgewood Growth Retail | 4.51% |
| HQH | Tekla Healthcare Investors | 4.30% |
| VWIGX | Vanguard International Growth Inv | 2.20% |
| ABPRX | AB Large Cap Growth R | 1.88% |
| VWUSX | Vanguard US Growth Investor | 1.59% |
| HRCAX | Harbor Capital Appreciation Admin | 1.44% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ILMN Tweets Stocktwits
Advertisement
